HelixCore Biotech
Certificate of Analysis
CJC w DAC 5mg
Lot CJC-2604-A
Product
- Product Name
- CJC w DAC 5mg
- Lot Number
- CJC-2604-A
- Vial Size
- 5mg
- Form
- Lyophilized powder
- Sequence / Formula
- DYADAIFTNSYRKVL-Aib-QLSARKLLQDIMSR-NH₂ + DAC
- Molecular Weight
- 3367.85 g/mol
- Release Date
- May 1, 2026
- Storage
- −20°C, protect from light
Analytical Results
| Test | Method | Specification | Result | Status |
|---|---|---|---|---|
| Identity | ESI Mass Spectrometry | Matches theoretical mass | Confirmed | PASS |
| Purity | Reverse-Phase HPLC (UV 220 nm) | ≥ 98.0% area | 99.9% | PASS |
| Endotoxin | LAL Kinetic Chromogenic | < 5.0 EU/mg | 0.13 EU/mg | PASS |
| Appearance | Visual | White lyophilized powder, free of foreign matter | Conforms | PASS |
Conclusion
Lot CJC-2604-A of CJC w DAC 5mgmeets HelixCore Biotech's release specifications and is approved for distribution as a research-use-only material. This product is not for human or veterinary use.
This certificate documents analytical testing performed on the lot identified above. Results apply to the tested lot only. HelixCore Biotech products are sold strictly for laboratory and research purposes — see the Research Use Only Policy for the full disclaimer.